Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK

BJU International

Volumn 83, Issue 4, 1999, Pages 410-415

  Trueman, P ^c   Hood, S C ^d   Nayak, U S L ^a   Mrazek, M F ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d NONE

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Prevalence; Quality of life; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; DEPRESSION; DISEASE SEVERITY; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PAIN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF CARE; SELF REPORT; SYMPTOM; UNITED KINGDOM; URETHRA;

AGED; AGED, 80 AND OVER; GREAT BRITAIN; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SELF DISCLOSURE; URINATION DISORDERS;

EID: 0032988661     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00966.x     Document Type: Article

References (21)

1. 1 Guess HA. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 247-61
2. 2 Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH. Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 1976; 7: 48-52
3. 3 Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 495-507
4. 4 Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469-71
5. 5 Oesterling JE. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. N Engl J Med 1995; 332: 99-109
6. 6 Simpson RJ. Fisher W, Lee AJ. Russell EB, Garraway M. Benign prostatic hyperplasia in an unselected community-based population: a survey of urinary symptoms, bother-someness and prostatic enlargement. Br J Urol 1996; 77: 186-91
7. 7 Bosch JL, Hop WC, Kirkels WJ, Schroder FH. Natural history of benign prostatic hyperplasia; appropriate case definition and estimation of its prevalence in the community. Urology 1995; 46: 34-40
8. 8 Brilton JP, Dowell AC, Whelan P. Prevalence of urinary symptoms in men over 60. Br J Urol 1990; 66: 175-6
9. 9 Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. Br J Urol 1993; 71: 290-6
10. 10 Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. The Prostate (Suppl) 1996; 6: 67-73
11. 11 The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
12. 12 Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993; 2: 167-8
13. 13 Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-9
14. 14 Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57
15. 15 Barry MJ, Fowler FJ. O'Leary MP et al. Correlation of the American Urological Association Symptom Index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program Indexes. J Urol 1992; 148: 1558-63
16. 16 Cockett AT, Aso Y et al. Recommendation of the International Consensus Committee on prostate symptom score and quality of life assessment. In Cockett ATK, Khoury S, Aso Y et al., eds. Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH) Paris: Scientific Communication International Ltd, 1994: 553-5
17. 17 Homma Y, Kawabe K, Tsukamoto T et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score. Int J Urol 1997; 4: 40-6
18. 18 Sagnier PP, Girman CJ, Garraway M et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29: 15-20
19. 19 Norman RW, Nickel JC, Fish D, Pickett SN. 'Prostate-related symptoms' in Canadian men 50 years of age or older; prevalence and relationships among symptoms. Br J Urol 1994; 74: 542-50
20. 20 Bosch JLHR, Hop WCJ, Kirkels WJ, Schroeder FH. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and relationships among symptoms. Br J Urol 1994; 74: 542-50
21. 21 Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: 85-9